ID: MRFR/HC/9250-HCR | August 2022 | Region: Global | 120 Pages
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterβs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on R&D
5.3.3. Regional Impact
5.3.4. Impact on Market Growth
6. GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE
6.1. Overview
6.2. Interventional
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
6.3. Observational
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
6.4. Others
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
7. GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY PHASE
7.1. Overview
7.2. Phase 1
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
7.3. Phase 2
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
7.4. Phase 3
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
7.5. Phase 4
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8. GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION
8.1. Overview
8.2. Oncology
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8.3. Cardiovascular
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8.4. Immunology
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8.5. Gastrointestinal
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8.6. Respiratory
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8.7. Endocrinology
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8.8. Ophthalmology
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8.9. Others
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
9. GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY REGION
9.1. Overview
9.2. North America
9.2.1. US
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. Italy
9.3.4. Spain
9.3.5. UK
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Virtual Clinical Trials Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Virtual Clinical Trials Market
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2020
10.8.2. Major Players R&D Expenditure, 2020
11. COMPANY PROFILES
11.1. Oracle Corporation
11.1.1. Company Overview
11.1.2. Products Offered
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. IQVIA Holdings, Inc.
11.2.1. Company Overview
11.2.2. Products Offered
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Dassault Systemes SE
11.3.1. Company Overview
11.3.2. Products Offered
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Medpace Holdings, Inc.
11.4.1. Company Overview
11.4.2. Products Offered
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Icon plc
11.5.1. Company Overview
11.5.2. Products Offered
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Laboratory Corporation of America Holdings
11.6.1. Company Overview
11.6.2. Products Offered
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Parexel International Corporation
11.7.1. Company Overview
11.7.2. Products Offered
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Medable, Inc.
11.8.1. Company Overview
11.8.2. Products Offered
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Clinical Ink, Inc.
11.9.1. Company Overview
11.9.2. Products Offered
11.9.3. Financial Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Wuxi AppTech
11.10.1. Company Overview
11.10.2. Products Offered
11.10.3. Financial Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Syneos Health
11.11.1. Company Overview
11.11.2. Products Offered
11.11.3. Financial Overview
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
β
LIST OF TABLES
TABLE 1 GLOBAL VIRTUAL CLINICAL TRIALS MARKET SYNOPSIS, 2018β2027
TABLE 2 GLOBAL VIRTUAL CLINICAL TRIALS MARKET ESTIMATES & FORECAST, 2018β2027 (USD MILLION)
TABLE 3 GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 4 GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 5 GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 6 GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY REGION, 2018β2027 (USD MILLION)
TABLE 7 NORTH AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY REGION, 2018β2027 (USD MILLION)
TABLE 8 NORTH AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 9 NORTH AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 10 NORTH AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 11 US: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 12 US: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 13 US: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 14 CANADA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 15 CANADA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 16 CANADA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 17 EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY REGION, 2018β2027 (USD MILLION)
TABLE 18 EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 19 EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 20 EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 21 GERMANY: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 22 GERMANY: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 23 GERMANY: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 24 UK: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 25 UK: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 26 UK: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 27 FRANCE: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 28 FRANCE: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 29 FRANCE: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 30 ITALY: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 31 ITALY: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 32 ITALY: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 33 SPAIN: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 34 SPAIN: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 35 SPAIN: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 36 REST OF EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 37 REST OF EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 38 REST OF EUROPE: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 39 ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY REGION, 2018β2027 (USD MILLION)
TABLE 40 ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 41 ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 42 ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 43 INDIA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 44 INDIA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 45 INDIA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 46 CHINA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 47 CHINA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 48 CHINA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 49 JAPAN: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 50 JAPAN: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 51 JAPAN: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 52 SOUTH KOREA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 53 SOUTH KOREA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 54 SOUTH KOREA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 55 AUSTRALIA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 56 AUSTRALIA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 57 AUSTRALIA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 58 REST OF ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 59 REST OF ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 60 REST OF ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 61 REST OF THE WORLD: VIRTUAL CLINICAL TRIALS MARKET, BY REGION, 2018β2027 (USD MILLION)
TABLE 62 REST OF THE WORLD: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 63 REST OF THE WORLD: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 64 REST OF THE WORLD: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 65 MIDDLE EAST: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 66 MIDDLE EAST: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 67 MIDDLE EAST: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 68 AFRICA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 69 AFRICA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 70 AFRICA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
TABLE 71 LATIN AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY STUDY TYPE, 2018β2027 (USD MILLION)
TABLE 72 LATIN AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY PHASE, 2018β2027 (USD MILLION)
TABLE 73 LATIN AMERICA: VIRTUAL CLINICAL TRIALS MARKET, BY INDICATION, 2018β2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL VIRTUAL CLINICAL TRIALS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL VIRTUAL CLINICAL TRIALS MARKET
FIGURE 4 GLOBAL VIRTUAL CLINICAL TRIALS MARKET SHARE, BY STUDY TYPE, 2020 (%)
FIGURE 5 GLOBAL VIRTUAL CLINICAL TRIALS MARKET SHARE, BY PHASE, 2020 (%)
FIGURE 6 GLOBAL VIRTUAL CLINICAL TRIALS MARKET SHARE, BY INDICATION, 2020 (%)
FIGURE 7 GLOBAL VIRTUAL CLINICAL TRIALS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 8 NORTH AMERICA: VIRTUAL CLINICAL TRIALS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 9 EUROPE: VIRTUAL CLINICAL TRIALS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 10 ASIA-PACIFIC: VIRTUAL CLINICAL TRIALS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 REST OF THE WORLD: VIRTUAL CLINICAL TRIALS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 12 GLOBAL VIRTUAL CLINICAL TRIALS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 13 ORACLE CORPORATION: KEY FINANCIALS
FIGURE 14 ORACLE CORPORATION: SWOT ANALYSIS
FIGURE 15 IQVIA HOLDINGS, INC.: KEY FINANCIALS
FIGURE 16 IQVIA HOLDINGS, INC.: SWOT ANALYSIS
FIGURE 17 DASSAULT SYSTEMES SE: KEY FINANCIALS
FIGURE 18 DASSAULT SYSTEMES SE: SWOT ANALYSIS
FIGURE 19 MEDPACE HOLDINGS, INC.: KEY FINANCIALS
FIGURE 20 MEDPACE HOLDINGS, INC.: SWOT ANALYSIS
FIGURE 21 ICON PLC: KEY FINANCIALS
FIGURE 22 ICON PLC: SWOT ANALYSIS
FIGURE 23 LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY FINANCIALS
FIGURE 24 LABORATORY CORPORATION OF AMERICA HOLDINGS: SWOT ANALYSIS
FIGURE 25 PAREXEL INTERNATIONAL CORPORATION: KEY FINANCIALS
FIGURE 26 PAREXEL INTERNATIONAL CORPORATION: SWOT ANALYSIS
FIGURE 27 MEDABLE, INC.: KEY FINANCIALS
FIGURE 28 MEDABLE, INC.: SWOT ANALYSIS
FIGURE 29 CLINICAL INK, INC.: KEY FINANCIALS
FIGURE 30 CLINICAL INK, INC.: SWOT ANALYSIS
FIGURE 31 WUXI APPTECH: KEY FINANCIALS
FIGURE 32 WUXI APPTECH: SWOT ANALYSIS
$11,239.0 million
5.89%
North America
2022-2030
The global virtual clinical trials market is expected to cross ~USD 11,239.0 million by 2027 at a CAGR of ~5.89%.
Market Overview:
Virtual clinical trials incorporate patient-facing technologies, such as tablets, smartphone apps, or wearable sensors. The virtual clinical trials are anticipated to use more of mobile technology, web-based patient diaries, wearable technologies and other digital approaches. Often, they are described as virtual trials, decentralized trials, remote trials, direct-to-patient trials, and hybrid trials. The market is driven by various factors such as increase in shift towards virtual clinical trials due to COVID-19 pandemic, rise in integration of mobile-based health platform and the increasing demand for flexibility of investigational site. However, the lack of regulations and need for data integration arising from large influx of data may hamper the growth of the market.
COVID-19 Analysis
The present COVID-19 pandemic has impacted people all over the world and forced the closure of operational facilities across the world. During the lockdown, the healthcare business faced extraordinary challenges such as supply chain disruptions, resulting in an increase in warehouse inventories of manufactured goods. However, the market for virtual clinical trials did not hamper to a great extent.
The COVID-19 pandemic also created growth opportunities for the companies involved in the virtual clinical trials industry. This is due to the increased R&D efforts to produce drugs for COVID-19, testing vaccines on clinical stage and benefits provided by virtual clinical trials to reduce contact between investigators and volunteers. Manufacturers of medical devices, pharmaceutical drugs, biologics and innovative therapies were engaged in continuing their ongoing clinical trials by shifting to hybrid model. Contract research organizations were focused on collaborating with technology providers to adopt to changing scenario for clinical trials during COVID-19 pandemic.
Market Dynamics
Report Attribute/Metric | Details |
---|---|
Market Size | 2027: ~USD 11,239 Million |
CAGR | ~5.89% |
Base Year | 2020 |
Forecast Period | 2021-2027 |
Historical Data | 2018 & 2019 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Study Type, Phase, and Indication |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | β’ Oracle Corporation (US) β’ IQVIA Holdings, Inc. (US) β’ Dassault Systemes SE (France) β’ Medpace Holdings, Inc. (US) β’ Icon plc (Ireland) β’ Laboratory Corporation of America Holdings (US) β’ Parexel International Corporation (US) β’ Medable, Inc. (Japan) β’ Clinical Ink, Inc. (US) β’ Wuxi AppTech (US) |
Key Market Opportunities | β’ Increasing need for virtual clinical trials |
Key Market Drivers | β’ Convenience provided as compared to traditional method β’ Integration of mobile-based health platform COVID-19 as a catalysis for virtual trials |